Notably, evidence for a possible involvement of ALK in colorectal cancer has already been suggested, mostly arguing for a cross-talk with EGFR and revealing the presence of tumors harboring both tyrosine kinase receptors alteration or ALK gene amplification as a poor prognostic factor [26]. This evidence concerns the gene NTRK1 and colorectal cancer.